Patents by Inventor Daniel M. Bernstein

Daniel M. Bernstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12566485
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various checks and combinations of checks including installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Grant
    Filed: January 23, 2024
    Date of Patent: March 3, 2026
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel M. Bernstein, Saeed Nekoomaram, Mark K. Sloan
  • Patent number: 12440126
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Grant
    Filed: June 23, 2023
    Date of Patent: October 14, 2025
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Daniel M. Bernstein, Martin J. Fennell, Michael R. Love, Kenneth J. Doniger, Songbiao Zhang, Mark K. Sloan, Hyun Cho, Theodore J. Kunich, Jean-Pierre Cole, Christopher A. Thomas, Erwin S. Budiman, David L. Li, Royce Cheng, Udo Hoss
  • Patent number: 12424326
    Abstract: Systems, devices, and methods are provided that allow detection of episodes in analyte measurement, prompting a patient to self-report possible causes for the episodes. Correlation of possible causes with detected episodes assists patient behavior modification to reduce the occurrence of episodes.
    Type: Grant
    Filed: April 9, 2021
    Date of Patent: September 23, 2025
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther, Daniel M. Bernstein, Eric L. Davis
  • Publication number: 20250191740
    Abstract: Systems, devices, and methods are provided that allow detection of episodes in analyte measurements and the prompting of a subject to self-report possible causes for the episodes and take action in response to episode detection. Correlation of possible causes with detected episodes assists patient behavior modification to reduce the occurrence of episodes. Also provided is function and structure for associating episodes with visits between the subject and a Health Care Provider (HCP) and scheduling interfaces and reports for assisting the HCP in advising numerous patients.
    Type: Application
    Filed: January 15, 2025
    Publication date: June 12, 2025
    Inventors: Gary A. Hayter, Michael R. Love, Roy Tsuchida, Nathan Crouther, Daniel M. Bernstein, Timothy C. Dunn, Richard J. Kedziora
  • Publication number: 20250166855
    Abstract: Presented herein is a handheld analyte measurement device. The analyte measurement device includes one or more software applications to help the user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with the handheld analyte measurement device.
    Type: Application
    Filed: November 15, 2024
    Publication date: May 22, 2025
    Inventors: Daniel M. Bernstein, Brittany K. Bradrick, Erwin S. Budiman, Eric Davis, Timothy C. Dunn, Mani Gopal, Wesley S. Harper, Gary A. Hayter, Steve Scott, Todd Winkler, Howard Wolpert
  • Patent number: 12290354
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Grant
    Filed: January 10, 2023
    Date of Patent: May 6, 2025
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Daniel M. Bernstein, Martin J. Fennell, Michael R. Love, Kenneth J. Doniger, Songbiao Zhang, Mark K. Sloan, Hyun Cho, Theodore J. Kunich, Jean-Pierre Cole, Christopher A. Thomas, Erwin S. Budiman, David L. Li, Royce Cheng, Udo Hoss
  • Publication number: 20250095869
    Abstract: Presented herein is a handheld analyte measurement device. The analyte measurement device includes one or more software applications to help the user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with the handheld analyte measurement device.
    Type: Application
    Filed: September 4, 2024
    Publication date: March 20, 2025
    Inventors: Daniel M. Bernstein, Brittany K. Bradrick, Erwin S. Budiman, Eric Davis, Timothy C. Dunn, Mani Gopal, Wesley S. Harper, Gary A. Hayter, Steve Scott, Todd Winkler, Howard Wolpert
  • Patent number: 12178617
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Grant
    Filed: July 1, 2019
    Date of Patent: December 31, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Publication number: 20240407736
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Application
    Filed: August 21, 2024
    Publication date: December 12, 2024
    Inventors: Timothy C. DUNN, Kenneth J. DONIGER, Glenn BERMAN, Gary A. HAYTER, Erwin S. BUDIMAN, Daniel M. BERNSTEIN, Nathan CROUTHER
  • Publication number: 20240366121
    Abstract: Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.
    Type: Application
    Filed: July 5, 2024
    Publication date: November 7, 2024
    Inventors: Mark K. SLOAN, Martin J. FENNELL, Daniel M. BERNSTEIN
  • Patent number: 12112854
    Abstract: Presented herein is a handheld analyte measurement device. The analyte measurement device includes one or more software applications to help the user manager their diabetes. Embodiments and descriptions of the various applications are provided below in conjunction with the handheld analyte measurement device.
    Type: Grant
    Filed: February 21, 2018
    Date of Patent: October 8, 2024
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Daniel M. Bernstein, Brittany K. Bradrick, Erwin S. Budiman, Eric Davis, Timothy C. Dunn, Mani Gopal, Wesley S. Harper, Gary A. Hayter, Steve Scott, Todd Winkler, Howard Wolpert
  • Patent number: 12102454
    Abstract: A system and method to provide guidance for diabetes therapy includes determining glycemic risks based on an analysis of glucose data. The analysis includes visualization of a glucose median, the variability of glucose in a patient, and the risk of hypoglycemia. An Advanced Daily Patterns report includes a visualization of an ambulatory glucose profile and a glucose control measure. The glucose control measure provides a highly visible and understandable display of the glucose condition of a patient visually expressed in the categories of low glucose, median glucose, and glucose variability.
    Type: Grant
    Filed: May 11, 2022
    Date of Patent: October 1, 2024
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Timothy C. Dunn, Kenneth J. Doniger, Glenn Berman, Gary A. Hayter, Erwin S. Budiman, Daniel M. Bernstein, Nathan Crouther
  • Publication number: 20240201775
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various checks and combinations of checks including installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Application
    Filed: January 23, 2024
    Publication date: June 20, 2024
    Inventors: Daniel M. BERNSTEIN, Saeed NEKOOMARAM, Mark K. SLOAN
  • Publication number: 20230346269
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Application
    Filed: June 23, 2023
    Publication date: November 2, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Gary A. HAYTER, Daniel M. BERNSTEIN, Martin J. FENNELL, Michael R. LOVE, Kenneth J. DONIGER, Songbiao ZHANG, Mark K. SLOAN, Hyun CHO, Theodore J. KUNICH, Jean-Pierre COLE, Christopher A. THOMAS, Erwin S. BUDIMAN, David L. LI, Royce CHENG, Udo HOSS
  • Patent number: 11737687
    Abstract: Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.
    Type: Grant
    Filed: January 21, 2019
    Date of Patent: August 29, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Mark K. Sloan, Martin J. Fennell, Daniel M. Bernstein
  • Publication number: 20230233112
    Abstract: Methods, apparatuses, and systems are provided for determining whether to administer a medication dose as a single dose or whether to fractionate the single dose to be administered as at least two discrete doses. Embodiments include determining a first analyte level and a first rate of change of the analyte level; determining an initial medication dose based on one or more anticipated subsequent medication doses, the first analyte level relative to an analyte level threshold, and the first rate of change of the analyte level relative to a rate of change threshold; administering the initial medication dose; determining a second analyte level and a second rate of change of the analyte level based on subsequent analyte data; and determining a subsequent medication dose based on the second analyte level relative to the analyte level threshold and the second rate of change relative to the rate of change threshold.
    Type: Application
    Filed: April 4, 2023
    Publication date: July 27, 2023
    Applicant: Abbott Diabetes Care Inc.
    Inventors: Mark K. SLOAN, Martin J. FENNELL, Daniel M. BERNSTEIN
  • Publication number: 20230143496
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Application
    Filed: January 10, 2023
    Publication date: May 11, 2023
    Inventors: Gary A. HAYTER, Daniel M. BERNSTEIN, Martin J. FENNELL, Michael R. LOVE, Kenneth J. DONIGER, Songbiao ZHANG, Mark K. SLOAN, Hyun CHO, Theodore J. KUNICH, Jean-Pierre COLE, Christopher A. THOMAS, Erwin S. BUDIMAN, David L. LI, Royce CHENG, Udo HOSS
  • Patent number: 11586273
    Abstract: Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device are provided. Various combinations of installation, functional, host integrity, coexistence, interoperability, power management, and environment checks are performed at various times to determine if the safety critical application operates properly on the device. The operation of the SCA on the UDPD may be controlled accordingly.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: February 21, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Daniel M. Bernstein, Saeed Nekoomaram, Mark K. Sloan
  • Patent number: 11571147
    Abstract: Methods of compensating for ambient temperature using temperature sensors, the method comprising: sampling at a first sampling rate, with a processor, first temperature measurements from a first temperature sensor on an on-body sensor. Then determining, with a processor, first ambient-compensated temperatures from the first temperature measurements; and determining, with a processor, final ambient-compensated temperatures by applying a correction gain or factor to the first ambient-compensated temperatures. Wherein the correction gain or factor changes value at a slower rate than the sampling rate.
    Type: Grant
    Filed: July 30, 2019
    Date of Patent: February 7, 2023
    Assignee: Abbott Diabetes Care Inc.
    Inventors: Gary A. Hayter, Daniel M. Bernstein, Martin J. Fennell, Michael R. Love, Kenneth J. Doniger, Songbiao Zhang, Mark K. Sloan, Hyun Cho, Theodore J. Kunich, Jean-Pierre Cole, Christopher A. Thomas, Erwin S. Budiman, David L. Li, Royce Cheng, Udo Hoss
  • Patent number: D994695
    Type: Grant
    Filed: August 13, 2021
    Date of Patent: August 8, 2023
    Assignee: ABBOTT DIABETES CARE INC.
    Inventors: Gary A. Hayter, Timothy C. Dunn, Nathan Crouther, Daniel M. Bernstein, Eric L. Davis